Stock Issued During Period, Value, New Issues

[Table of Co](#i2c056a9f8317485ea6601862f5b0559f_7)[ntents](#i2c056a9f8317485ea6601862f5b0559f_7)AMEREN CORPORATIONCONSOLIDATED STATEMENT OF SHAREHOLDERS’ EQUITY(In millions)

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | December 31, |
|  | 2021 |  | 2020 |  | 2019 |
| Common Stock: |  |  |  |  |  |
| Beginning of year | $ | 3  |  |  | $ | 2  |  |  | $ | 2  |  |
| Settlement of forward sale agreement through common shares issuance | —  |  |  | 1  |  |  | —  |  |
| Common stock, end of year | 3  |  |  | 3  |  |  | 2  |  |
|  |  |  |  |  |  |
| Other Paid-in Capital: |  |  |  |  |  |
| Beginning of year | 6,179  |  |  | 5,694  |  |  | 5,627  |  |
| Settlement of forward sale agreement through common shares issuance | 113  |  |  | 424  |  |  | —  |  |
| Shares issued under the ATM program | 148  |  |  | —  |  |  | —  |  |
| Shares issued under the DRPlus and 401(k) plan | 47  |  |  | 51  |  |  | 68  |  |
| Stock-based compensation activity | 15  |  |  | 10  |  |  | (1) |  |
|  |  |  |  |  |  |
| Other paid-in capital, end of year | 6,502  |  |  | 6,179  |  |  | 5,694  |  |
|  |  |  |  |  |  |
| Retained Earnings: |  |  |  |  |  |
| Beginning of year | 2,757  |  |  | 2,380  |  |  | 2,024  |  |
| Net income attributable to Ameren common shareholders | 990  |  |  | 871  |  |  | 828  |  |
| Dividends on common stock | (565) |  |  | (494) |  |  | (472) |  |
|  |  |  |  |  |  |
| Retained earnings, end of year | 3,182  |  |  | 2,757  |  |  | 2,380  |  |
|  |  |  |  |  |  |
| Accumulated Other Comprehensive Income (Loss): |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
| Deferred retirement benefit costs, beginning of year | (1) |  |  | (17) |  |  | (22) |  |
| Change in deferred retirement benefit costs | 14  |  |  | 16  |  |  | 5  |  |
|  |  |  |  |  |  |
| Deferred retirement benefit costs, end of year | 13  |  |  | (1) |  |  | (17) |  |
| Total accumulated other comprehensive gain (loss), end of year | 13  |  |  | (1) |  |  | (17) |  |
| Total Shareholders’ Equity | $ | 9,700  |  |  | $ | 8,938  |  |  | $ | 8,059  |  |
|  |  |  |  |  |  |
| Noncontrolling Interests: |  |  |  |  |  |
| Beginning of year | 142  |  |  | 142  |  |  | 142  |  |
| Net income attributable to noncontrolling interest holders | 5  |  |  | 6  |  |  | 6  |  |
| Dividends paid to noncontrolling interest holders | (5) |  |  | (6) |  |  | (6) |  |
| Redemptions of Ameren Illinois preferred stock | (13) |  |  | —  |  |  | —  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
| Noncontrolling interests, end of year | 129  |  |  | 142  |  |  | 142  |  |
| Total Equity | $ | 9,829  |  |  | $ | 9,080  |  |  | $ | 8,201  |  |
|  |  |  |  |  |  |
|  |  |  |  |  |  |
| Common stock shares outstanding at beginning of year | 253.3  |  |  | 246.2  |  |  | 244.5  |  |
| Shares issued under forward sale agreement | 1.6  |  |  | 5.9  |  |  | —  |  |
| Shares issued under the ATM program | 1.8  |  |  | —  |  |  | —  |  |
| Shares issued under the DRPlus and 401(k) plan | 0.5  |  |  | 0.7  |  |  | 0.9  |  |
| Shares issued for stock-based compensation | 0.5  |  |  | 0.5  |  |  | 0.8  |  |
| Common stock shares outstanding at end of year | 257.7  |  |  | 253.3  |  |  | 246.2  |  |
|  |  |  |  |  |  |
| Dividends per common share | $ | 2.20  |  |  | $ | 2.00  |  |  | $ | 1.92  |  |

The accompanying notes are an integral part of these consolidated financial statements.89
